MITROFLOW AORTIC PERICARDIAL HEART VALVE
Report
- Report Number
- 3004478276-2010-00009
- Event Type
- Other
- Date Received
- October 28, 2010
- Date of Event
- September 25, 2010
- Report Date
- October 28, 2010
- Manufacturer
- SORIN GROUP CANADA INC. MITROFLOW DIVISION
- Product Code
- LWR
- PMA / PMN Number
- P060038
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- NURSE
Narratives
EVAL METHOD: A REVIEW OF THE DEVICE HISTORY RECORD WAS COMPLETED. RESULTS: THE MFG TRAVELLER AND THE STERILIZATION RECORDS FOR THE SUBJECT VALVE WERE PULLED AND REVIEWED BY QUALITY ASSURANCE AT SORIN GROUP (B)(4), MITROFLOW DIVISION. THE RESULTS CONFIRMED THAT THIS VALVE SATISFIED ALL MATERIAL, VISUAL, AND PERFORMANCE STANDARDS REQUIRED FOR A SIZE 25 MITROFLOW AORTIC PERICARDIAL HEART VALVE AT THE TIME OF MANUFACTURE AND RELEASE. NOTE: AS PART OF THE INVESTIGATION, THE REVIEW OF THE STERILIZATION RECORDS CONFIRMED THAT THE FOUR VALVES (S/NS (B)(4)) ASSOCIATED WITH THE ENDOCARDITIS CASES AT THIS FACILITY WERE NOT PROCESSED IN THE SAME STERILIZATION LOT.
THE COMPANY WAS NOTIFIED THAT OUT OF 19 MITROFLOW VALVE IMPLANTS AT THE CUSTOMER'S FACILITY SINCE (B)(6) 2010, 4 PTS WERE DIAGNOSED WITH ENDOCARDITIS. FOR EACH CASE, STAPH EPIDERMIDIS WAS IDENTIFIED AS THE RESPONSIBLE ORGANISM. THE IMPLANTS OCCURRED IN (B)(6) 2010. ACCORDING TO THE INFO PROVIDED ON (B)(4), THE PT RECEIVING THE MITROFLOW VALVE (S/N (B)(4)) ON (B)(6) 2010, WAS DIAGNOSED WITH POSSIBLE ENDOCARDITIS AFTER BEING SEEN IN THE ED FOR SHAKING, CHILLS, AND FEVER ON (B)(6) 2010. BLOOD CULTURES WERE PERFORMED AND STAPHYLOCOCCUS EPIDERMIDIS WAS ISOLATED. A TEE WAS PERFORMED AND SHOWED NO VEGETATION AND THAT THE VALVE APPEARED OK.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | MITROFLOW AORTIC PERICARDIAL HEART VALVE | TISSUE, HEART VALVE | LWR | SORIN GROUP CANADA INC. MITROFLOW DIVISION | LXA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |